Description

Butanoic Acid, 2-[(1,3-Dihydro-1,3-Dioxo-2H-Isoindol-2-Yl)Oxy]-3-Methyl-,(2S)- is a specialized chiral organic compound featuring a phthalimide-protected hydroxyl group on a butanoic acid backbone. This molecule matters as a high-value pharmaceutical intermediate or chiral building block for the synthesis of complex active ingredients. It is primarily needed by R&D chemists and process development scientists in the pharmaceutical and fine chemical industries.

Application

• Pharmaceutical Intermediate: Key chiral synthon in the research and production of novel therapeutic agents, particularly for stereospecific APIs.
• Protease Inhibitor Synthesis: Potential building block for the development of enzyme inhibitors targeting specific proteolytic pathways.
• Peptidomimetic Chemistry: Used in constructing peptide analogs and mimetics due to its carboxylic acid and protected amino-alcohol functionality.
• Asymmetric Synthesis: Serves as a chiral starting material or auxiliary in catalytic asymmetric reactions to induce stereoselectivity.
• Chemical Biology Research: Tool compound for probing biological mechanisms and developing activity-based probes.
• Fine Chemical Production: Intermediate in the multi-step synthesis of complex, high-value specialty chemicals.

Basic Information

Item	Details
Product Name	Butanoic Acid, 2-[(1,3-Dihydro-1,3-Dioxo-2H-Isoindol-2-Yl)Oxy]-3-Methyl-,(2S)-
CAS No.	688031-83-6
Molecular Formula	C13H13NO5
Molecular Weight	263.25 g/mol
Synonyms	(2S)-2-[(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)oxy]-3-methylbutanoic acid; (S)-2-((1,3-Dioxoisoindolin-2-yl)oxy)-3-methylbutanoic acid; 2-Phthalimidooxy-3-methylbutyric acid, (S)-; N-Phthaloyl-L-allothreonine derivative; L-Configured phthalimide-protected hydroxy acid; Chiral butanoic acid phthalimide ester
EINECS	Contact for details

Quality Control

Our products undergo rigorous quality testing to ensure compliance with industry standards. For this advanced intermediate, we typically control chiral purity, chemical purity, and specific impurities. Certificates of Analysis (COA) are available upon request, detailing parameters such as assay, enantiomeric excess, and identification. We adhere to cGMP principles where applicable for pharmaceutical-grade material.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, well-ventilated area at a controlled room temperature (typically 15-25°C). The compound may be hygroscopic (moisture-sensitive); keep the container tightly sealed under an inert atmosphere if specified.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Assay (HPLC)	≥ 98.0%
Enantiomeric Purity (Chiral HPLC)	≥ 99.0% ee
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.